BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Pramlintide

Severe Hypoglycemia

  • SYMLIN use with insulin increases the risk of severe hypoglycemia, particularly in patients with type 1 diabetes. When severe hypoglycemia occurs, it is seen within 3 hours following a SYMLIN injection. Serious injuries may occur if severe hypoglycemia occurs while operating a motor vehicle, heavy machinery, or while engaging in other high-risk activities. Appropriate patient selection, careful patient instruction, and insulin dose reduction are critical elements for reducing this risk.

Approved Risk Evaluation and Mitigation Strategies (REMS)

 

Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts

Pramlintide

Updated January 2018